BioLineRx (BLRX) Total Current Liabilities (2010 - 2026)
BioLineRx's Total Current Liabilities came in at $13.68 million for the quarter ended Jun 30, 2026, down 11.6% from $15.48 million a year earlier but up 0.4% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Total Current Liabilities (2010 - 2026) Analysis & Trends
As of Dec 31, 2025, BioLineRx's Total Current Liabilities was $12.12 million, down 21.3% from the prior year.
- Total Current Liabilities carries a five-year compound annual growth rate of 2.6% (years ended Dec 2020 to Dec 2025).
- Going back by year, Total Current Liabilities was $15.41 million in the year ended Dec 31, 2024 (-64.0%), $42.78 million in the year ended Dec 31, 2023 (+300.6%), $10.68 million in the year ended Dec 31, 2022 (+9.9%) and $9.72 million in the year ended Dec 31, 2021 (-8.7%).
- The five-year range for quarterly Total Current Liabilities is $8.13 million (the quarter ended Sep 30, 2022) to $42.78 million (the quarter ended Dec 31, 2023).
- Year-over-year, Total Current Liabilities has declined for seven consecutive quarters, with an average decline of 22.5% over the last eight quarters.
- The fastest year-over-year change in Total Current Liabilities over five years came in the quarter ended Dec 31, 2023 (growth of 300.6%), and the weakest in the quarter ended Dec 31, 2024 (a decline of 64.0%).
- Business Quant data shows BLRX's Total Current Liabilities at $13.62 million (quarter ended Mar 31, 2026), $12.12 million (quarter ended Dec 31, 2025) and $13.67 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | BioLineRx | 6.34 Bn | 6.35 Bn | 235,000.00 | 13.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.68 Mn |
| Mar 31, 2026 | 13.62 Mn |
| Dec 31, 2025 | 12.12 Mn |
| Sep 30, 2025 | 13.67 Mn |
| Jun 30, 2025 | 15.48 Mn |
| Mar 31, 2025 | 14.03 Mn |
| Dec 31, 2024 | 15.41 Mn |
| Sep 30, 2024 | 24.96 Mn |
| Jun 30, 2024 | 30.52 Mn |
| Mar 31, 2024 | 31.37 Mn |
| Dec 31, 2023 | 42.78 Mn |
| Sep 30, 2023 | 14.73 Mn |
| Jun 30, 2023 | 12.45 Mn |
| Mar 31, 2023 | 12.04 Mn |
| Dec 31, 2022 | 10.68 Mn |
| Sep 30, 2022 | 8.13 Mn |
| Jun 30, 2022 | 9.63 Mn |
| Mar 31, 2022 | 9.10 Mn |
| Dec 31, 2021 | 9.72 Mn |
| Sep 30, 2021 | 10.31 Mn |
API Access
BioLineRx Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();